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Impact of temperature, energy output and impedance drop during renal
denervation on the long-termn outcome
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1HELIOS Klinkum, Wuppertal, Germany, 2HelELIOS Klinikum, Wuppertal,
Germany
Background: Renal denervation (RDN) through catheter ablation is emerging as a
promising therapeutic option for refractory hypertension, but the decrease in blood
pressure (BP) is difficult to predict and is usually evident only after months. No acute
variable is available to date to predict the BP response.
Methods: This analysis is based on 23 patients with RDN performed at our institution
within the last 14 months. Complete information regarding all ablation points was present
for 18 patients (194 ablation points). 15 patients had complete 3-months follow-up
including 24-hour BP, and for 10 of these patients the complete information regarding the
ablation points was present.
Results: 20 patients had a bilateral RDN with 4,51,2 ablation points per renal artery,
2 patients only monolateral due to 40% narrowing of the other artery. One patients
experienced asystoly after ostial RDN of the first renal artery requiring CPR and
intubation. He received a pacemaker and recovered completely. 79,9% of ablation points
required the max. energy output (8W). The BP decreased from 151/77 to 134/72 mmHg
(P0.07 for syst. RR) and the percentage of patients with systolic BP 140mmHg from
57% to 31% (P0,04) on an average of 3,80,9 medications.
Conclusions: RDN can reduce hypertensive peaks. Marked suppression of sympathetic
activity can cause bradycardia and hypotension and requires alert supervision during
ablation. Impedance drop correlates highly significant with ablation temperature and
seems to correlate better with long term reduction of mean BP than ablation temperature,
suggesting an impact of impedance drop on outcome.
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Background: Catheter-based intravascular renal denervation (RD) using radiofrequency
energy has shown promise in the treatment of resistant hypertension. However, to date, no
studies have examined the extent of renal nerve injury following RD.
Methods: To examine renal nerve injury following RD, nine obese, hypertensive dogs
underwent bilateral RD using the St. Jude Medical EnligHTN™ renal denervation system
and eight weeks of hemodynamic monitoring. At the end of the eight-week period, both
left and right renal arteries were collected from the aorta to the kidneys. The renal arteries
were cut into equal sections, fixed, and embedded in paraffin. Multiple five-micron
sections were taken from the bifurcation, main renal artery, and the ostium and stained
with hematoxylin-eosin. Sections were examined for the total number of nerves, number
of injured nerves, and the distance measured from nerves to the renal artery lumen.
Results: Renal nerves were found from 0.28 mm to 6.7 mm from the renal artery lumen.
Twelve percent of the nerves were found between 0.28mm and 1mm from the artery
lumen, fifty-seven percent between 1mm and 2.5 mm, seventeen percent between 2.5mm
and 3.5mm, and fourteen percent between 3.5mm and 6.7mm. Forty-two percent of
nerves exhibited injury due to RD (157 out of 371); however, since samples were
examined 8 weeks after RD, some injured nerves may have degenerated and become
unobservable. Injury was found at nearly all distances from the artery lumen but was most
prevalent from 0.28mm to 3.5mm. Renal nerve injury was found in thirty-six percent of
the nerves near the bifurcation, forty-one percent in the main renal artery, and fifty-six
percent near the ostium.
Conclusions: Our data show that renal nerves span a great distance from the renal artery
lumen in obese canines. These data also suggest that the RD travels approximately 3.5mm
from the artery lumen surface in obese dogs; however, renal nerve injury is noted further
out. The injury further from the luminal surface is presumably the result of Wallerian-type
degeneration. The current study showed that RD using the St. Jude Medical EnligHTN™
renal denervation system does cause significant injury to renal nerves.
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Background: Renal Sympathetic Denervation (RSD) is a novel, device-based interven-
tion for the management of resistant essential hypertension (RH). Here we present the data
from our initial experience of renal artery denervation for the first 12 patients.
Methods: All patients in this pilot study (n12) had RH, and were on a minimum of 3
medications. The effect of RSD on office blood pressure, 24 hour ambulatory blood
pressure, number of anti-hypertensive medications, renal function, weight, serum uric acid
concentration, excretory fraction of sodium, and renin-aldosterone levels was investi-
gated. We also assessed the safety of the procedure. Prior to intervention secondary causes
of hypertension were excluded, and detailed anatomy of the renal arteries was obtained
using either CT or MR angiography. Patients were followed up at 2 weeks, 2 months and
6 months for serum biochemistry, urinalysis and office BP. Ambulatory BP was assessed
pre- and 2 months post RSD.
Results: At 2 months the average decrease in office BP was 33/15mmHg (systolic p 
0.04, diastolic p0.03), while the observed reduction in 24 hour ambulatory BP readings
was 26/16mmHg (systolic p0.01, diastolic p0.01). The range in change of serum
creatinine values at 2 months was10 to	13 mol/L, and the average change was	1.5
mol/L (p0.47). There was a 6.6% reduction in mean uric acid concentration
(p0.371). A trend towards weight loss, with an average reduction in weight of 1.65kg
at 2 month follow up was seen (p 0.27). Patients required, on average, 1.3 medications
less at follow up. There have been no major complications to date.
Conclusions: RSD was safe, and effective at reducing both systolic and diastolic blood
pressure in patients with RH. No acute deterioration in renal function was demonstrated.
Findings from this pilot study showed more substantial reductions in ambulatory BP
consistent with larger studies.
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Background: Sympathetic renal denervation shows promise in treating resistant hyper-
tension. The percutaneous RF ablation approach is currently undergoing evaluation but
has several limitations. Vascular brachytherapy has the potential to damage nerves. The
purpose of the present study was to assess safety and feasibility of renal artery
brachytherapy for sympathetic renal denervation.
Methods: A total of 10 normotensive domestic swine underwent vascular brachytherapy
to left and right renal arteries using the Beta-Cath™ 3.5F System with doses of 25 Gy and
50 Gy at 2 mm from the source center. Each treated group had 8 arteries; 4 untreated
arteries served as control. Follow-up obtained at 1 or 2 months included angiogram,
intravascular ultrasound, norepinephrine levels and histopathology.
Results: Overall the vascular brachytherapy procedure was safe and there were no
apparent angiographic or ultrasound injuries to the vessel. Histology demonstrated a
variable degree of thermal injury more pronounced in the 50 Gy group. The majority of
the examined nerves showed some degree of injury. (Figure) There was a dose-related
effect on the severity of the nerve injury. There was a varied degree of arteriolar changes
in the examined sections; most showed a varied degree of endothelial cell loss of
approximately 2% to 20%.
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